The Effects of Oral Probiotic Supplementation in Postmenopausal Women with Overweight and Obesity: A Systematic Review and Meta-analysis of Randomized Controlled Trials

• Published in: Probiotics and antimicrobial proteins Vol. 15; no. 6; pp. 1567 - 1582
• Main Authors: Li, Zijun, Li, Yanfei, Pan, Bei, Wang, Xiaoman, Wu, Yu, Guo, Ke, Yang, Minyan, Ma, Mina, Qiao, Chengdong, Yang, Kehu
• Format: Journal Article
• Language: English
• Published: New York Springer US 01-12-2023; Springer Nature B.V
• Subjects: Adipose tissue; Applied Microbiology; Biomedical and Life Sciences; Body weight; Cardiovascular diseases; Chemistry/Food Science; Clinical trials; Dietary supplements; Glucose metabolism; Inflammation; Intestinal microflora; Life Sciences; Meta-analysis; Metabolism; Microbiology; Nutrition; Obesity; Overweight; Post-menopause; Probiotics; Protein Science; Reviews; Systematic review; Tumor necrosis factor-α; Probiotics; Postmenopausal women; Obese; Cardiovascular diseases; Overweight
• ISSN: 1867-1306; 1867-1314
• DOI: 10.1007/s12602-022-10037-3

Gut microbiota has been identified as a unique endocrine organ linked to the development of cardiovascular disease and other illnesses, especially deteriorated in overweight and obese postmenopausal women. The object of this systematic review and meta-analysis aimed to assess the effects of oral supplementation with probiotics for overweight and obese postmenopausal women. We performed a systematic search for randomized controlled trials (RCTs) from inception to April 2022 in MEDLINE, Embase, Cochrane Library, Web of Science, and ClinicalTrials.gov. We also performed a hand search by reviewing reference lists to identify trials. The risk of bias in individual studies was assessed with the Cochrane risk of bias tool for randomized trials (RoB). Two reviewers independently selected studies and collected data. There were 6 studies from 5 RCTs with 281 participants in this systematic review. Compared with the placebo, the probiotics supplementation group had reductions in insulin (MD − 4.20 IU/L (95% CI − 8.11 to − 0.30 IU/L),
I
2
 = 54%), HOMA-IR (MD − 1.25 (95% CI − 2.49 to − 0.01),
I
2
 = 50%), and TNF-α (MD − 0.12 pg/mL (95% CI − 0.22 to − 0.01 pg/mL),
I
2
 = 44%). Improvements were also shown in body adiposity and lipid profile, but these effects were nonsignificant. In addition to body adiposity and cardiovascular risk markers, one trial showed the administration of probiotics also had an effect on iron metabolism. In conclusion, probiotics have a potential benefit on glucose metabolism and inflammatory process in overweight and obese postmenopausal women, but this effect is mild. It demonstrates that oral probiotics supplementation can be a complementary treatment for improving the fitness of postmenopausal women with overweight and obesity.